The market for of Hematide and the revenue potential once it hits the market is absolutely enormous. Yet AFFY is priced like a value play. You wanna get rich, buy some here, and keep buying. No joke. Hematide might take a couple more years to get through its trials, but by then AFFY will be much much higher. It might be difficult to hold in the mean time, but it will be very much worth it, in my opinion.